Plain-English translation of NCT03011541 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study tests whether bone marrow-derived stem cells—special cells harvested from your own bone marrow—can help improve vision in people who have lost sight due to retinal or optic nerve damage. The stem cells will be injected directly into or around your eye using several different injection methods. You'll be monitored for 12 months with regular eye exams to see whether the treatment helps restore or stabilize your vision.
Many eye diseases that cause vision loss are considered permanent and currently have no effective treatment options. This trial explores whether stem cell therapy might be able to repair or regenerate damaged eye tissue and restore sight in patients who have exhausted other treatment options.
You likely qualify if…
You likely don't qualify if…
If you qualify, doctors will harvest stem cells from your bone marrow using standard surgical techniques, then inject these cells into or around your affected eye (or both eyes if needed) using several injection methods. You will then return for comprehensive eye exams and imaging tests at regular intervals over 12 months to assess whether your vision has improved or stabilized.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
United States
Austria
United Arab Emirates